Literature DB >> 21054184

Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccination.

Ruth C Carlos1, Amanda F Dempsey, Ken Resnicow, Mack T Ruffin, Divya A Patel, Christopher M Straus, Andrew Kure, Vanessa K Dalton.   

Abstract

PURPOSE: Breast or cervical cancer screening visits may present an opportunity to motivate mothers to have their daughters vaccinated against human papillomavirus (HPV). In preparation for a future intervention study, we sought to establish the feasibility of using these visits to identify women with at least one daughter in the appropriate age range for adolescent HPV vaccination.
METHODS: We conducted a cross-sectional mailed survey of women who had received breast or cervical cancer screening within the 6-18 months before the survey. The study was conducted at two diverse institutions: one serving a mostly black (54.1%) urban inner-city population and another serving a mostly white (87.5%) suburban population.
RESULTS: Our overall response rate was 28% (n = 556) in the urban site and 38% (n = 381) in the suburban site. In the urban site, the proportions of mothers completing mammography or Pap smear visits with HPV vaccine-eligible daughters were 23% and 24%, respectively. In the suburban site, the proportions of mothers completing mammography or Pap smear with at least one vaccine-eligible daughter were 41% and 26%, respectively.
CONCLUSIONS: Women who undergo breast or cervical cancer screening in the two different demographic groups evaluated have at least one adolescent daughter at the appropriate age for HPV vaccination. An important implication of this finding in adolescent daughters of urban mothers is the potential use of maternal breast or cervical cancer screening encounters to target a potentially undervaccinated group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054184      PMCID: PMC2990278          DOI: 10.1089/jwh.2010.1959

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  17 in total

1.  Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.

Authors:  S D Womack; Z M Chirenje; P D Blumenthal; L Gaffikin; J A McGrath; T Chipato; E Ngwalle; K V Shah
Journal:  BJOG       Date:  2000-01       Impact factor: 6.531

Review 2.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

4.  Cervical cancer prevention through human papillomavirus vaccination: using the "teachable moment" for educational interventions.

Authors:  Ruth C Carlos; Amanda F Dempsey; Divya A Patel; Vanessa K Dalton
Journal:  Obstet Gynecol       Date:  2010-04       Impact factor: 7.661

5.  Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV.

Authors:  Amanda F Dempsey; Gregory D Zimet; Robert L Davis; Laura Koutsky
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Authors:  Amanda Dempsey; Lisa Cohn; Vanessa Dalton; Mack Ruffin
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

7.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

8.  Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls.

Authors:  Dena S Cox; Anthony D Cox; Lynne Sturm; Greg Zimet
Journal:  Health Psychol       Date:  2010-01       Impact factor: 4.267

Review 9.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

10.  Cancer in developing countries.

Authors:  D M Parkin
Journal:  Cancer Surv       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.